Hani Naseef

521 total citations
47 papers, 298 citations indexed

About

Hani Naseef is a scholar working on Infectious Diseases, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Hani Naseef has authored 47 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Pharmaceutical Science and 6 papers in Molecular Biology. Recurrent topics in Hani Naseef's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Antibiotic Use and Resistance (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Hani Naseef is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Antibiotic Use and Resistance (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Hani Naseef collaborates with scholars based in Palestinian Territory, Greece and United States. Hani Naseef's co-authors include M. Efentakis, Marilena Vlachou, Ni’meh Al-Shami, P. A. Tarantili, A. G. Andreopoulos, Fuad Al‐Rimawi, Donia Karaman, Sabino Aurelio Bufo, Laura Scrano and Amin Mahmood Thawabteh and has published in prestigious journals such as BMC Cancer, Pharmaceutics and BMC Infectious Diseases.

In The Last Decade

Hani Naseef

42 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hani Naseef Palestinian Territory 10 54 43 31 29 28 47 298
Mehdi Rajabi Iran 12 20 0.4× 45 1.0× 31 1.0× 17 0.6× 37 1.3× 38 458
Mohammad Asif India 12 34 0.6× 49 1.1× 37 1.2× 12 0.4× 11 0.4× 54 500
Wael Abu Dayyih Jordan 12 26 0.5× 59 1.4× 27 0.9× 15 0.5× 57 2.0× 84 441
Lidwien M. Hanff Netherlands 15 80 1.5× 14 0.3× 28 0.9× 28 1.0× 47 1.7× 40 566
Nadia Saffoon Bangladesh 7 53 1.0× 22 0.5× 23 0.7× 25 0.9× 14 0.5× 15 433
Béatrice Demoré France 11 38 0.7× 23 0.5× 25 0.8× 26 0.9× 96 3.4× 57 477
Ziba Islambulchilar Iran 12 123 2.3× 34 0.8× 14 0.5× 9 0.3× 42 1.5× 27 330
A. Tekle Saudi Arabia 12 15 0.3× 51 1.2× 24 0.8× 34 1.2× 29 1.0× 23 320
Celso Henrique de Oliveira Brazil 13 16 0.3× 93 2.2× 19 0.6× 39 1.3× 74 2.6× 25 359
Jean-Marc Aiache France 12 134 2.5× 69 1.6× 71 2.3× 25 0.9× 53 1.9× 46 405

Countries citing papers authored by Hani Naseef

Since Specialization
Citations

This map shows the geographic impact of Hani Naseef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Naseef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Naseef more than expected).

Fields of papers citing papers by Hani Naseef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hani Naseef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Naseef. The network helps show where Hani Naseef may publish in the future.

Co-authorship network of co-authors of Hani Naseef

This figure shows the co-authorship network connecting the top 25 collaborators of Hani Naseef. A scholar is included among the top collaborators of Hani Naseef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hani Naseef. Hani Naseef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Shami, Ni’meh, et al.. (2024). HPLC Method Development and Validation for the Determination of Apixaban and Clopidogrel in Novel Fixed-Dose Combination Tablets. Journal of Chemistry. 2024. 1–11. 5 indexed citations
2.
Al-Shami, Ni’meh, et al.. (2024). Adherence to ADA Clinical Guidelines in Type 2 Diabetes Management in Public Health Clinics in Palestine. Patient Preference and Adherence. Volume 18. 2667–2680.
3.
Al-Shami, Ni’meh, et al.. (2024). Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross-Sectional Study, Palestine. The Scientific World JOURNAL. 2024. 1–10. 1 indexed citations
4.
Al-Shami, Ni’meh, et al.. (2024). Practices, Efficacy, and Reported Side Effects Associated with Isotretinoin Treatment in Palestine. Patient Preference and Adherence. Volume 18. 487–501. 2 indexed citations
5.
Al-Shami, Ni’meh, et al.. (2024). COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine. International Journal of General Medicine. Volume 17. 3349–3360.
6.
Al-Shami, Ni’meh, et al.. (2024). ESKAPE Pathogens: Antimicrobial Resistance Patterns, Risk Factors, and Outcomes a Retrospective Cross-Sectional Study of Hospitalized Patients in Palestine. Infection and Drug Resistance. Volume 17. 3813–3823. 6 indexed citations
7.
Al-Shami, Ni’meh, et al.. (2023). Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community. BMC Infectious Diseases. 23(1). 5–5. 16 indexed citations
8.
Ali, Ola A. Abu, et al.. (2023). Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study. International Journal of General Medicine. Volume 16. 141–150. 1 indexed citations
9.
Naseef, Hani, et al.. (2023). Quality of Life of Palestinian Patients on Hemodialysis: Cross-Sectional Observational Study. The Scientific World JOURNAL. 2023. 1–8. 3 indexed citations
10.
Naseef, Hani, et al.. (2023). Quantitative Analysis of Favipiravir by HPLC: Development and Validation. International Journal of Analytical Chemistry. 2023. 1–9. 3 indexed citations
11.
Naseef, Hani, et al.. (2023). The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets. Pharmaceuticals. 16(10). 1412–1412. 5 indexed citations
12.
Naseef, Hani, et al.. (2023). Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine. Clinical Epidemiology and Global Health. 22. 101330–101330. 2 indexed citations
14.
15.
Naseef, Hani, et al.. (2022). A retrospective evaluation of drug–drug interactions in patients admitted to Internal Medicine Departments in Palestinian Hospitals. SAGE Open Medicine. 10. 3911989304–3911989304. 1 indexed citations
16.
Naseef, Hani, et al.. (2022). Novel Fusidic Acid Cream Containing Metal Ions and Natural Products against Multidrug-Resistant Bacteria. Pharmaceutics. 14(8). 1638–1638. 3 indexed citations
17.
Naseef, Hani, et al.. (2022). Vitamin D Deficiency Association with Comorbid Diseases in Palestine: “A Cross-Sectional Observation Study”. International Journal of General Medicine. Volume 15. 8033–8042. 1 indexed citations
18.
Naseef, Hani, et al.. (2022). Evaluation of Self-Medication with Antibiotics in Primary Care Clinics in Palestine. Patient Preference and Adherence. Volume 16. 2877–2892. 7 indexed citations
19.
Al-Shami, Ni’meh, et al.. (2022). VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines. Vascular Health and Risk Management. Volume 18. 701–710. 2 indexed citations
20.
Efentakis, M., Hani Naseef, & Marilena Vlachou. (2010). Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Drug Development and Industrial Pharmacy. 36(8). 903–916. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026